Clincosm LogoSign in Get a demo

Renal Cell Carcinoma

Showing NaN - NaN of 28
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Biomarkers of Renal Cancer

Recruiting
  • Renal Cell Carcinoma
  • +3 more
    • Firenze, Italy
    • +3 more
    Mar 14, 2023

    Renal Cell Carcinoma Trial in Worldwide (Atezolizumab, Placebo)

    Completed
    • Renal Cell Carcinoma
    • Scottsdale, Arizona
    • +185 more
    Jan 30, 2023

    Renal Cell Carcinoma Trial in Worldwide (Cabozantinib, Nivolumab, Ipilimumab)

    Active, not recruiting
    • Renal Cell Carcinoma
    • La Jolla, California
    • +159 more
    Jan 23, 2023

    Renal Cell Carcinoma Trial in Worldwide (Nivolumab, Ipilimumab, Ipilimumab )

    Active, not recruiting
    • Renal Cell Carcinoma
    • Nivolumab
    • +2 more
    • Washington, District of Columbia
    • +77 more
    Jan 6, 2023

    Gastric Cancer, Renal Cell Carcinoma, Melanoma Trial in United States (HFB200301)

    Recruiting
    • Gastric Cancer
    • +8 more
    • Scottsdale, Arizona
    • +9 more
    Dec 22, 2022

    Colorectal Cancer, NSCLC, Triple Negative Breast Cancer Trial in Spain, United Kingdom, United States (GEN1029

    Terminated
    Has Results
    • Colorectal Cancer
    • +6 more
    • GEN1029 (HexaBody®-DR5/DR5)
    • New Haven, Connecticut
    • +5 more
    Nov 11, 2022

    Soft Tissue Sarcoma, Renal Cell Carcinoma, Uterine Carcinosarcoma Trial in United States (HFB301001)

    Recruiting
    • Soft Tissue Sarcoma
    • +4 more
    • Scottsdale, Arizona
    • +9 more
    Sep 13, 2022

    Breast Cancer, Cholangiocarcinoma, Colorectal Cancer Trial in Worldwide (Entrectinib)

    Recruiting
    • Breast Cancer
    • +15 more
    • Goodyear, Arizona
    • +146 more
    Aug 24, 2022

    Tumor Malignant, Renal Cell Carcinoma, Hormone Receptor Positive Breast Carcinoma Trial in Worldwide (XL092, Atezolizumab,

    Recruiting
    • Neoplasm Malignant
    • +5 more
    • Duarte, California
    • +55 more
    Aug 17, 2022

    Renal Cell Carcinoma Trial in Worldwide (Lenvatinib, Everolimus, Pembrolizumab)

    Active, not recruiting
    Has Results
    • Renal Cell Carcinoma
    • Stanford, California
    • +182 more
    Jul 1, 2022

    Melanoma, Renal Cell Carcinoma, Non Small Cell Lung Cancer Trial in Worldwide (Combination of NKTR-214 + nivolumab)

    Completed
    • Melanoma
    • +6 more
    • Combination of NKTR-214 + nivolumab
    • La Jolla, California
    • +57 more
    Jun 22, 2022

    Thyroid, Renal Cell Carcinoma, Non Small Cell Lung Cancer Trial in Worldwide (SO-C101, pembrolizumab)

    Recruiting
    • Thyroid
    • +18 more
    • New Haven, Connecticut
    • +6 more
    Apr 8, 2022

    Lung Tumors, NSCLC, Carcinoma, Small Cell Trial in Worldwide (CK-301 (cosibelimab))

    Recruiting
    • Lung Neoplasms
    • +12 more
    • CK-301 (cosibelimab)
    • Wollongong, New South Wales, Australia
    • +47 more
    Mar 3, 2022

    Squamous Cell Carcinoma of the Head and Neck, Melanoma, Non Small Cell Lung Cancer Trial in Worldwide (SL-279252)

    Recruiting
    • Squamous Cell Carcinoma of the Head and Neck
    • +12 more
    • Nashville, Tennessee
    • +4 more
    Feb 3, 2022

    Renal Cell Carcinoma Trial in Worldwide (Atezolizumab (MPDL3280A), an engineered anti-PD-L1 antibody, Bevacizumab, Sunitinib)

    Completed
    Has Results
    • Renal Cell Carcinoma
    • Atezolizumab (MPDL3280A), an engineered anti-PD-L1 antibody
    • +2 more
    • Tucson, Arizona
    • +153 more
    Jan 13, 2022

    Spanish Real-World Evidence Cabozantinib

    Recruiting
    • Renal Cell Carcinoma
    • Córdoba, Andalucía, Spain
    • +31 more
    Sep 21, 2021

    Renal Cell Carcinoma Trial in Worldwide (Atezolizumab, Bevacizumab, RO6874281)

    Completed
    • Renal Cell Carcinoma
    • New Haven, Connecticut
    • +22 more
    Sep 10, 2021

    Renal Cell Carcinoma Trial in Worldwide (Cabozantinib tablets, Everolimus (Afinitor) tablets)

    Completed
    Has Results
    • Renal Cell Carcinoma
    • Cabozantinib tablets
    • Everolimus (Afinitor) tablets
    • Birmingham, Alabama
    • +204 more
    Apr 1, 2021

    Epithelial Ovarian Cancer, Renal Cell Carcinoma Trial in Worldwide (HKT288)

    Terminated
    • Epithelial Ovarian Cancer
    • Renal Cell Carcinoma
    • Houston, Texas
    • +5 more
    Dec 6, 2020

    Solid Tumor, Non Small Cell Lung Cancer, Renal Cell Carcinoma Trial in Worldwide (LY3381916, LY3300054)

    Terminated
    • Solid Tumor
    • +3 more
    • Indianapolis, Indiana
    • +11 more
    Jun 8, 2020

    Renal Cell Carcinoma Trial in Worldwide (Atezolizumab (MPDL3280A), an Engineered Anti-PD-L1 Antibody, Bevacizumab, Sunitinib)

    Completed
    Has Results
    • Renal Cell Carcinoma
    • Atezolizumab (MPDL3280A), an Engineered Anti-PD-L1 Antibody
    • +2 more
    • Scottsdale, Arizona
    • +44 more
    Dec 19, 2019

    Advanced Renal Cell Carcinoma, Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma Trial in Worldwide (Standard Treatment,

    Terminated
    • Advanced Renal Cell Carcinoma
    • +2 more
    • Standard Treatment
    • AGS-003
    • Scottsdale, Arizona
    • +124 more
    Jun 13, 2018

    RCC With Bone Metastases, HRQoL and Comparison of Imaging

    Terminated
    • Renal Cell Carcinoma
      • Oviedo, Asturias, Spain
      • +11 more
      Apr 25, 2018

      Renal Cell Carcinoma Trial in Worldwide (Everolimus, GDC-0980)

      Completed
      • Renal Cell Carcinoma
      • Fort Myers, Florida
      • +21 more
      Aug 8, 2016

      Renal Cell Carcinoma Trial in Worldwide (Bevacizumab, Temsirolimus, Interferon-Alfa 9MU)

      Completed
      Has Results
      • Renal Cell Carcinoma
      • Little Rock, Arkansas
      • +171 more
      Mar 25, 2016